Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.200
+0.010 (0.84%)
At close: Aug 12, 2026, 4:00 PM EDT
1.207
+0.007 (0.56%)
After-hours: Aug 12, 2026, 4:54 PM EDT

Bionano Genomics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
15.3328.5130.7836.1227.817.98
Revenue Growth
-44.09%-7.37%-14.79%29.90%54.62%111.47%
Gross Profit
6.7813.190.389.575.953.87
Operating Income
-17.09-33.34-103.98-215.25-131.7-77.1
Net Income
-16.45-26.4-112.02-232.49-132.6-72.44
Earnings Per Share
-3.02-4.85-88.13-408.60-274.80-156.00
EPS Growth
------

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Americas (excl. United States)
7.678.7410.098.045.04
Europe, The Middle East and Africa (EMEA)
14.1114.2312.968.965.6
Asia Pacific
2.222.89---
United States
4.514.917.935.824.29
Total
28.5130.7836.1227.817.98

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.9219.279.4866.77113.19250.61
Total Debt
6.716.8927.379.4111.6710.7
Net Cash (Debt)
3.222.38-17.82-12.64101.52239.92
Net Cash Growth
-----57.69%984.42%
Net Cash Per Share
0.340.44-14.02-22.22210.61520.08

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-10.1-16.35-68.92-125.18-124.82-71.93
Capital Expenditures
---0.1-1.69-3.2-1.46
Free Cash Flow
-10.1-16.35-69.03-126.87-128.02-73.39
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
44.20%46.25%1.23%26.49%21.38%21.55%
Operating Margin
-111.45%-116.95%-337.87%-595.98%-473.70%-428.79%
Pretax Margin
-106.98%-92.35%-363.87%-643.57%-470.15%-434.64%
Profit Margin
-107.30%-92.59%-363.97%-643.74%-476.93%-402.84%
FCF Margin
-65.90%-57.33%-224.28%-351.29%-460.46%-408.14%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.450.581.052.3915.6148.16